Anemia of End Stage Renal Disease

Hematology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Avalo Therapeutics
1 program
1
MDGN201 TARGTEPOPhase 21 trial
Active Trials
NCT02468414TerminatedEst. Sep 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Avalo TherapeuticsMDGN201 TARGTEPO

Clinical Trials (1)

NCT02468414Avalo TherapeuticsMDGN201 TARGTEPO

TARGTEPO Treatment for Anemia in PD US Trial

Start: Jun 2015Est. completion: Sep 2016
Phase 2Terminated

Related Jobs in Hematology

Senior Manager – Strategy & Business Transformation

Johnson & Johnson
Mumbai, India
2d ago

MSL Hematología L - Sur

Johnson & Johnson
Sevilla, Spain
2d ago

Délégué Médical LLC/Myélome (H/F) - secteurToulouse

Johnson & Johnson
Issy-les-Moulineaux, France
2d ago

Sr. Director Marketing

Genetix Biotherapeutics
Somerville, Massachusetts, United States
4d ago
From $270K/yr

Commercial Strategy Lead – Innovative Gene Therapies (Haematology - BeNeLux)

Vertex Pharmaceuticals
5065 - Vertex Netherlands
5d ago

Key Account Specialist Hematology

Johnson & Johnson
Beirut, Lebanon
5d ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Anemia(92)Myelofibrosis(21)Polycythemia Vera(16)Primary Immune Thrombocytopenia(15)Primary Myelofibrosis(14)Immune Thrombocytopenia(12)Thrombocytopenia(11)Beta-Thalassemia(10)Aplastic Anemia(7)Anemia of Chronic Kidney Disease(7)